| Typicality: | 0.385 |
| Saliency: | 0.315 |
| in 2016 | 2 | temporal |
| recently | 2 | temporal |
| colleague → conduct → clinical trials | 5 |
| colleague → conduct → clinical trial | 4 |
| colleague → conduct → a phase 3 trial | 3 |
| negative | neutral | positive |
| 0.077 | 0.834 | 0.089 |
| Raw frequency | 12 |
| Normalized frequency | 0.315 |
| Modifier score | 0.500 |
| Perplexity | 140.500 |